#DRREDDY BUY SETUP There is no consistency in the concept of Buy Low, Sell High. If you want to be successful in the markets you must Buy High, Sell Higher...
DRREDDY trade ideas
#DREDDY BUY SETUP NOW *******************DAILY FINANCIAL WISDOM: "A year from now you will have wished you had truly started learning to trade today..."
Indian Pharma Sector Stocks - It Is All About RotationSo what's ailing Indian Pharma sector stocks? Those who really looked like on steroids are suddenly behaving like they have swallowed over dose of laxatives. Few environmental changes are to blame,
1. ) Rotation
Yes folks, those who rode it from Rs. 100 a stock to 1500 are taking profit and putting that money to some other sector where they believe market it going to perform well. Look at Reliance, a single stock has gobbled up many thousand crore in its rally. From where that money came to buy such stocks in other sector? Of course some from new gullible SIP investors ( more on that in upcoming post :) ) etc and some from rotation.
2. ) Change In Tone of Governments
Still it's difficult to justify the quantitative effect on Pharma stocks but certainly this is also a factor which will keep on weighing the stocks in future. Many countries are being rhetoric about fixing the drug prices and that is headline risk as well as bottom line risk.
3. ) Too Much Good Has Been Priced In
How much is too much?! ;) That question is never going to have perfect answer in stock market because it's all about psychology. But in general, when anybody look at the chart and say, wow what a rise of few hundred or thousand percent gain ! then it is time to be cautious. Because even though fundamentals are supportive for such rise, market needs confirmation and will wait to digest such meteoric rise.
We had great trades in Pharma stocks like,
Dr Reddy
Cipla
Glaxo
Lupin
Auropharma
Divis Laboratories etc..
But now it is time to pause and let them collapse until they become attractive again !
DRREDDY LOOK BULLISH IN MEDIUM TERM -27/7/2017DAILY FINANCIAL WISDOM: Amateur traders focus on rewards. Professional traders focus on risk..
BUY SETAP NOWDAILY FINANCIAL WISDOM: "If you always do what you've always done, you will always get what you've always got...."
DR REDDYS LAB LONG TARGET 2900 TO 3000inverted head and shoulder in dr reddys lab, in the rise of nifty, pharma stocks are left behind will drreddy lab cover the back log. likely to go for targets of 2900 to 3000 in around one month.
near long term bottomnear long term bottom...risk reward ratio makes it a better choice for positional trader
Looks like the stock is headed higherLooks like the stock is headed higher. The volume is slowly picking up..looking for target of 3100 and more.
Classic ABCD pattern in DRREDDYNSE:DRREDDY
Classic ABCD pattern has formed in daily chart of DRREDDY. The C point has formed at 0.62 and CD has formed at 1.56 of "BC". Bullish Entry can be made at 2990 for a target of 3250. SL 2960.
www.tradingview.com
Bullish pattern in DRREDDYNSE:DRREDDY
Bullish Classic ABCD pattern has formed in daily chart of DRREDDY. The C point has formed at 0.62 and CD has formed at 1.56 of BC. Entry can be made at 2990 for a target of 3200. SL 2960.
DRREDDY in BUY modeFundamentally a STRONG company and it had recent news for its upmove
Dr Reddy's Laboratories has expanded strategic collaboration with Amgen, one of the world's leading independent biotechnology companies, to market and distribute three of Amgen's medicines in India in the therapy areas of oncology and osteoporosis. Under the terms of the collaboration, the company will commercialise XGEVA'(denosumab), Vectibix' (panitumumab) and Prolia (donosumab) in India.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750.00 on 21-Jan-2016.
The promoters holding in the company stood at 26.37%, while institutions and non-institutions held 41.16% and 15.64% respectively.
Dr. Reddy’s Laboratories has been listed as an Index component of the Dow Jones Sustainability Indices (DJSI) 2016 in the Pharmaceuticals, Biotechnology & Life Sciences Industry Group. The pharma major has been recognized for its corporate sustainability leadership and is the only pharmaceutical company on the Index of Emerging Markets.
The listing was based on 22 criterion, with Dr. Reddy’s receiving high scores for Product Quality and Recall Management, Codes of Business Conduct, Environmental Reporting, Corporate Citizenship and Philanthropy.
Dr REDDY - ALL SET TO FILL GAP (BUY)There was a gap down observed on daily chart which is been not filled up for a long time. Now the price action breaks out from a rectangular consolidation and shall reach out to 3280 levels in order to fill up that GAP.
Target: 3280
Stoploss: 3070
DRREDDY A GOOD INVESTMENT AND TRADING STOCKENTRY 2950-300 RANGE
SL 2850
TGT 1 : 3300
TGT 2 : 3600
TGT 3 : 4400
Dr Reddy's Lab Stock Is Technically Challenged - 7/25/2016India's one of the biggest drug maker is going to release quarterly results soon and its stock is already feeling the jitters. Analysts and news papers will annotate the appropriate headline but someone who is aware about the technicals will of course be taking profit at this levels. A solid up trend from the beginning of 2009 is still in effect but it is going to be challenged soon. Sock price is random but they usually don't stop at random points which you can surmise by looking that attached charts. Even a huge drop from 4400 stopped at 2800. Well, that is not a coincidence for sure. Good stocks should always be traded with long bias and long side is more rewarding in long term for stocks ! But nothing wrong in taking profit time to time when you feel that the run has enough. We have been actively trading Dr Reddy with amalgamation of stocks, options and futures. So right now we have deployed our favorite strategy of selling covered calls on long positions.
After Dr Reddy's quarterly result release tomorrow, following levels are going to be very interesting and this is how we are planning to trade it.
Near 4000 / 4200 resistance - Covered call selling on most positions with liquidation of stocks too. And probably switch to short side by buying puts.
3200 / 3000 support - cover existing covered calls and trading it from buy side.
Indian pharma trade is very simple. Buy when FDA helps us to get it with bargain and sell when all is good and stock starts sputter at lofty heights.
Our other recent pharma trade, Cipla Limited longs are looking very promising and we may add to the position during dips targetting 560 / 600.
Sell DrreddyAs we can see a nice Bearish engulfing in this stock as we can short this stock might see some selling pressure.
Here we will move SL as we achieve 1:1 to BE.
If someone wants to do options ca sell 3500 ce and buy 3600 ce .
Happy trading :)
Dr.Reddy's Lab: Accumulation or Re-Distribution?Interesting chart. Watching price action for more clues !! Breakout above upper end of the range accompanied by higher volume would tilt the scale in favor of accumulation.
